Inhibition of T cell-mediated inflammation in uveitis by a novel anti-CD3 antibody.

about

Inhibition of T cell-mediated inflammation in uveitis by a novel anti-CD3 antibody.

Item

http://www.wikidata.org/entity/Q41117094

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Inhibition of T cell-mediated inflammation in uveitis by a novel anti-CD3 antibody.

@en

type

Item

label

Inhibition of T cell-mediated inflammation in uveitis by a novel anti-CD3 antibody.

@en

prefLabel

Inhibition of T cell-mediated inflammation in uveitis by a novel anti-CD3 antibody.

@en

P1476

Inhibition of T cell-mediated inflammation in uveitis by a novel anti-CD3 antibody.

@en

P2093

Hiroshi Keino

http://www.w3.org/2001/XMLSchema#string

Jun Shimizu

http://www.w3.org/2001/XMLSchema#string

Kenichi Makabe

http://www.w3.org/2001/XMLSchema#string

Masayo Takahashi

http://www.w3.org/2001/XMLSchema#string

Sunao Sugita

http://www.w3.org/2001/XMLSchema#string

Takeshi Watanabe

http://www.w3.org/2001/XMLSchema#string

P2860

Release of tumor necrosis factor, interleukin-2, and gamma-interferon in serum after injection of OKT3 monoclonal antibody in kidney transplant recipients

Anti-CD3 antibody ameliorates experimental autoimmune uveitis by inducing both IL-10 and TGF-β dependent regulatory T cells.

Modulation of the human T cell response by a novel non-mitogenic anti-CD3 antibody

Interleukin 12 protects from a T helper type 1-mediated autoimmune disease, experimental autoimmune uveitis, through a mechanism involving interferon gamma, nitric oxide, and apoptosis.

Involvement of Th17 cells and the effect of anti-IL-6 therapy in autoimmune uveitis

Prophylactic use of OKT3 monoclonal antibody in cadaver kidney recipients. Utilization of OKT3 as the sole immunosuppressive agent.

Treatment of acute renal allograft rejection with OKT3 monoclonal antibody.

Inhibition of Th17 differentiation by anti-TNF-alpha therapy in uveitis patients with Behçet's disease.

Genetic control of susceptibility to experimental autoimmune uveoretinitis in the mouse model. Concomitant regulation by MHC and non-MHC genes.

Evaluation of mouse experimental autoimmune uveoretinitis by spectral domain optical coherence tomography.

P2888

s13075-017-1379-9

P304

176

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S13075-017-1379-9

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-07-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1090893646

http://www.w3.org/2001/XMLSchema#string

P698

28743289

http://www.w3.org/2001/XMLSchema#string

P921

uveitis

P932

5526238

http://www.w3.org/2001/XMLSchema#string